Precision Biosensor, Inc. (KOSDAQ:335810)

Precision Biosensor Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,310	1,723	2,426	7,557	5,544	21,904
Short-Term Investments	1,179	2,095	4,090	1,093	17,140	2,068
Cash & Short-Term Investments	3,489	3,818	6,517	8,650	22,683	23,972
Cash Growth	-36.41%	-41.41%	-24.66%	-61.87%	-5.38%	118.22%
Accounts Receivable	1,973	1,735	1,821	1,657	2,305	2,797
Other Receivables	579.84	683.29	646.08	332.68	439.78	605.54
Receivables	3,117	3,109	2,467	1,989	2,745	3,403
Inventory	8,986	8,994	9,234	9,639	7,524	4,693
Prepaid Expenses	119.93	107.21	108.06	155.74	212.39	115.49
Other Current Assets	362.45	342.33	118.9	336.03	130.72	195.06
Total Current Assets	16,075	16,371	18,445	20,771	33,295	32,379
Property, Plant & Equipment	29,979	30,836	33,469	27,806	15,490	9,207
Long-Term Investments	1,500	1,500	5,000	5,000	5,000	-0
Other Intangible Assets	2,539	2,676	3,225	3,759	24.16	0.21
Long-Term Deferred Tax Assets	-	-	477.37	370.25	164	-
Other Long-Term Assets	496.9	656.59	1,171	612.62	1,746	692.9
Total Assets	50,590	52,039	62,478	59,010	55,718	42,279
Accounts Payable	610.81	545.06	430.28	769.13	902.86	901.9
Accrued Expenses	1,230	1,172	979.08	585.07	680.54	376.56
Short-Term Debt	7,746	5,962	4,644	8,113	-	-
Current Portion of Long-Term Debt	6,000	6,000	3,000	3,000	-	-
Current Portion of Leases	719.12	746.6	703.94	725.23	104.41	314.68
Other Current Liabilities	6,214	4,966	3,588	6,849	463.86	2,237
Total Current Liabilities	22,520	19,391	13,345	20,041	2,152	3,830
Long-Term Debt	3,000	4,375	10,786	3,000	9,325	518
Long-Term Leases	431.35	579.31	1,165	1,717	222.34	154.74
Other Long-Term Liabilities	201.56	1,416	4,560	230.17	5,353	-
Total Liabilities	26,906	26,341	30,451	25,634	17,365	5,058
Common Stock	5,807	5,807	5,807	5,796	5,683	5,622
Additional Paid-In Capital	58,401	58,301	57,599	54,415	53,224	48,110
Retained Earnings	-41,576	-39,561	-32,132	-27,361	-20,699	-16,357
Comprehensive Income & Other	1,052	1,150	753.8	525.75	145.8	-153.5
Shareholders' Equity	23,684	25,698	32,027	33,375	38,353	37,221
Total Liabilities & Equity	50,590	52,039	62,478	59,010	55,718	42,279
Total Debt	17,897	17,663	20,299	16,555	9,652	987.42
Net Cash (Debt)	-14,408	-13,845	-13,783	-7,904	13,032	22,985
Net Cash Growth	-	-	-	-	-43.30%	121.94%
Net Cash Per Share	-1242.28	-1192.03	-1187.80	-685.77	1154.32	2552.51
Filing Date Shares Outstanding	11.59	11.61	11.61	11.59	11.37	11.24
Total Common Shares Outstanding	11.59	11.61	11.61	11.59	11.37	11.24
Working Capital	-6,445	-3,021	5,099	729.46	31,143	28,548
Book Value Per Share	2044.30	2212.54	2757.53	2879.32	3374.36	3310.34
Tangible Book Value	21,145	23,021	28,803	29,616	38,329	37,221
Tangible Book Value Per Share	1825.14	1982.12	2479.87	2555.06	3372.23	3310.32
Land	9,037	9,037	9,037	7,542	2,723	2,723
Buildings	14,974	14,974	14,953	7,685	7,685	1,643
Machinery	13,964	13,973	10,701	10,412	7,655	3,281
Construction In Progress	127.35	111.35	2,792	4,793	764	3,782

Source: S&P Global Market Intelligence. Standard template. Financial Sources.